Bibliographie (2546)
Cohort study: Younger children may be more likely to transmit SARS-CoV-2 infection in households compared with older children, the risk being higher for contacts of children aged 0 to 3 years.
mardi, 17 août 2021 11:22 Écrit par Zouhair SouissiAssociation of Age and Pediatric Household Transmission of SARS-CoV-2 Infection – JAMA Pediatrics Editorial: Yes, Children Can Transmit COVID, but We Need Not Fear Commentary on Twitter (thread – click for more) A new, large Ontario study of >6000 households (>1700 w/ secondary attacks) concludes that younger children (0-3 years) may transmit covid more […]
The post Cohort study: Younger children may be more likely to transmit SARS-CoV-2 infection in households compared with older children, the risk being higher for contacts of children aged 0 to 3 years. appeared first on Links Medicus.
Systematic review: Systemic corticosteroids for the treatment of COVID‐19.
mardi, 17 août 2021 11:22 Écrit par Zouhair SouissiSystemic corticosteroids for the treatment of COVID‐19 – Cochrane Library Summary: Are corticosteroids given orally or by injection an effective treatment for people with COVID-19? – Cochrane Library Commentary on Twitter (thread – click for more) JUST PUBLISHED – Systemic #corticosteroids for the treatment of #COVID19 from @CochraneHaem – https://t.co/l4V993gLzj 1/5 pic.twitter.com/Vjk4aHXKFV — The […]
The post Systematic review: Systemic corticosteroids for the treatment of COVID‐19. appeared first on Links Medicus.
Antibody responses after a single dose of AstraZeneca Covid-19 vaccine in previously infected individuals were similar or higher compared to SARS-CoV-2 naïve participants who received two doses of Pfizer mRNA vaccine.
lundi, 16 août 2021 03:23 Écrit par Zouhair SouissiAntibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2 – EBioMedicine Commentary (on the preprint): Single dose of Oxford-AstraZeneca vaccine protective in previously infected recipients, suggests study – News Medical Related: More data showing one dose of Pfizer vaccine may be enough for individuals who’ve had COVID. […]
The post Antibody responses after a single dose of AstraZeneca Covid-19 vaccine in previously infected individuals were similar or higher compared to SARS-CoV-2 naïve participants who received two doses of Pfizer mRNA vaccine. appeared first on Links Medicus.
Perspective | Don’t panic, but breakthrough cases may be a bigger problem than you’ve been told.
lundi, 16 août 2021 03:23 Écrit par Zouhair SouissiDon’t Panic, But Breakthrough Cases May Be a Bigger Problem Than You’ve Been Told – Intelligencer Commentary on Twitter (thread – click for more) The vaccines are still performing quite well in preventing severe disease. But with Delta they are doing much worse in stopping transmission. Breakthroughs are probably now 10-20% of new infections, […]
The post Perspective | Don’t panic, but breakthrough cases may be a bigger problem than you’ve been told. appeared first on Links Medicus.
FDA authorizes additional Covid-19 vaccine dose for certain immunocompromised individuals – Other fully vaccinated individuals do not need an additional vaccine dose right now.
lundi, 16 août 2021 03:23 Écrit par Zouhair SouissiCoronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals – U.S. Food & Drug Administration Commentaries: Statement on FDA Authorization of Supplemental Vaccine Dose for Immunocompromised Patients – Infectious Diseases Society of America CDC, FDA recommend COVID booster for immune-compromised – CIDRAP FDA authorizes additional dose of Covid-19 vaccine for the immunocompromised […]
The post FDA authorizes additional Covid-19 vaccine dose for certain immunocompromised individuals – Other fully vaccinated individuals do not need an additional vaccine dose right now. appeared first on Links Medicus.
Opinion: Time for a smart approach to boosters.
vendredi, 13 août 2021 12:16 Écrit par Zouhair SouissiTime for a Smart Approach to Boosters – Think Global Health
The post Opinion: Time for a smart approach to boosters. appeared first on Links Medicus.
How do vaccinated people spread Delta? What the science says.
vendredi, 13 août 2021 12:16 Écrit par Zouhair SouissiHow do vaccinated people spread Delta? What the science says – Nature
The post How do vaccinated people spread Delta? What the science says. appeared first on Links Medicus.
How COVID-19 will change the management of other respiratory viral infections.
vendredi, 13 août 2021 12:16 Écrit par Zouhair SouissiHow COVID-19 will change the management of other respiratory viral infections – Intensive Care Medicine Commentary on Twitter Still in the midst of #SARSCoV2 #pandemic, still so much to learn… but #COVID19 experience should transform approach to research on RVIs?antiviral therapy?corticosteroids?specific immune modulation?anticoagulation?respiratory support#COVIDFOAM https://t.co/WVKRSJARvl pic.twitter.com/qMkB4tkz06 — Intens Care Med (@yourICM) August 11, 2021 […]
The post How COVID-19 will change the management of other respiratory viral infections. appeared first on Links Medicus.
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.
vendredi, 13 août 2021 12:16 Écrit par Zouhair SouissiKawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison – American Family Physician Related: Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children. Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, there was no evidence that recovery differed after primary treatment with intravenous immune globulin (IVIG) […]
The post Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison. appeared first on Links Medicus.
Opinion | Could this be our first effective, inexpensive, widely available outpatient treatment for COVID-19? (It’s fluvoxamine).
vendredi, 13 août 2021 12:16 Écrit par Zouhair SouissiCould This Be Our First Effective, Inexpensive, Widely Available Outpatient Treatment for COVID-19? – HIV and ID Observations Related: Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19
The post Opinion | Could this be our first effective, inexpensive, widely available outpatient treatment for COVID-19? (It’s fluvoxamine). appeared first on Links Medicus.
![[Preprint] Pfizer vs. Moderna COVID-19 vaccine effectiveness against the Delta variant in Qatar – Effectiveness against symptomatic disease due to Delta was 53.5% for Pfizer and 84.8% for Moderna; effectiveness against severe disease due to Delta was 89.7](/media/k2/items/cache/2be14c7bf5e582e3d07cf6fdbe198e16_XS.jpg)
